CompletedNot Applicable

Adenoid Hypertrophy, Respiratory Complications and Correlation With Infant Feeding Position

Israel500 participantsStarted 2003-01-01

Plain-language summary

500 children aged 0-5 years followed since birth by Principal Investigator (PI)since January1, 2003 till December 31, 2018 and diagnosed with adenoid hypertrophy (AH) (study group) and 500 children aged 0-5 years followed by principal investigator during the same years and diagnosed as urinary tract infection (UTI), gastroenteritis (GE), diarrhea, vomiting but without AH (control group) were compared. Morbidity and treatment will be compared and correlated with gastro-esophageal reflux (GER), allergy and infant feeding position during the first few years of life in the two groups.

Who can participate

Age range1 Month – 5 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Study group: Young children with diagnosis of adenoid hypertrophy followed by PI Control group: young children with diagnosis of UTI, GE, vomiting or diarrhea followed by PI Exclusion Criteria: Children with cystic fibrosis, primary dyskinesia, immune deficiency, congenital anatomical malformations of nasal or airway passages. Children older than 6 months of age when starting to be followed by PI.

What they're measuring

Respiratory complications

Timeframe: 3 years

Ear complications

Timeframe: 3 years

Trial details

NCT IDNCT04431128

SponsorHadassah Medical Organization

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-12-31

View on ClinicalTrials.gov More Adenoid Hypertrophy trials